企業プロフィール
Aditxt, Inc. 株価・ニュース・カタリスト
- ティッカー:
- ADTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (-12.82%)
終値
最終更新: 2026年10月1日
89.6K USD
時価総額
株価変動の要因
2026年10月1日 時点で ADTX は 12.8% 下落し、$0.0034 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Immune Health Technology Company
Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics. Its business is organized through subsidiaries and licensed platforms rather than a single therapeutic franchise.
Adimune Immune Modulation
Adimune holds rights to nucleic-acid-based technology intended to retrain immune responses. The platform is being explored for autoimmune and other immune-mediated diseases through preclinical and development programs.
AditxtScore Immune Monitoring
AditxtScore is designed to provide a personalized profile of immune status. The technology evaluates antibody and cellular responses and can support monitoring of infection, vaccination, and immune health.
Pearsanta Precision Diagnostics
Pearsanta is developing mitochondrial-DNA-based biomarkers for diseases including prostate cancer and endometriosis. Earlier discovery work has also identified potential biomarker signatures in additional cancers.
Subsidiary and Transaction Model
Aditxt forms or acquires subsidiaries around distinct technologies and seeks outside financing, partnerships, and acquisitions to expand them. This structure creates multiple development tracks but also makes execution dependent on transaction completion and capital availability.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。